Day: March 25, 2020
TORONTO, March 25, 2020 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of March 2020 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on April 15, 2020 to unitholders of record on March 31, 2020.As previously announced, SmartCentres will be suspending the Distribution Reinvestment Plan (the “DRIP”), effective April 13, 2020. As a result, unitholders will receive distributions in cash only, effective with the current distribution scheduled to be paid on April 15, 2020, to unitholders of record on March 31, 2020. Upon reinstatement of the DRIP, plan participants enrolled in the DRIP at the time of its suspension will remain enrolled at...
Viela Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
Written by Customer Service on . Posted in Public Companies.
GAITHERSBURG, Md., March 25, 2020 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today reported financial results and provided program highlights for the fourth quarter and full year ended December 31, 2019.“2019 was a pivotal year for Viela as we achieved many important financial, clinical and regulatory milestones. Supported by our recently completed initial public offering, we ended the year with a strong cash position, enabling continued pipeline growth and expansion,” said Bing Yao, Ph.D., Chief Executive Officer at Viela Bio. “With a Biologics License Application (BLA) under review by the U.S. Food and Drug Administration (FDA) for our lead product candidate inebilizumab for the treatment of neuromyelitis optica spectrum...
Firsthand Technology Value Fund Discloses Top Portfolio Holdings
Written by Customer Service on . Posted in Public Companies.
SAN JOSE, Calif., March 25, 2020 (GLOBE NEWSWIRE) — Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of February 29, 2020, were Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and Hera Systems.The Fund also announced that as of February 29, 2020, the estimated total investments* of the Fund were approximately $118 million, or $17.06 per share, including cash and cash equivalents of approximately $0.24 per share. As of that date, the Fund’s top five holdings constituted 88.6% of the Fund’s estimated total investments*. Complete financial statements and a detailed schedule of investments as of March 31, 2020, will be available in the Fund’s quarterly report filing on Form...
HP Issues Letter to Shareholders
Written by Customer Service on . Posted in Public Companies.
PALO ALTO, Calif., March 25, 2020 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) today issued the following letter to shareholders:Dear HP Shareholder,As a community, we are all focused on managing the unprecedented COVID-19 pandemic with urgency and a deep sense of care. We are committed to doing everything we can to support those in need and respond to the challenges at hand. This pandemic is still unfolding, and it will impact people, the economy and business activities for months, if not longer.At the same time, we are committed to protecting your investment in HP. Since Xerox launched its unsolicited exchange offer and nominated directors, the global social, economic and financial environments have changed radically. Despite this, Xerox continues to advance its tender offer and its proposed slate of directors in an effort to force...
Williams Reports Fourth Quarter 2019 Financial Results
Written by Customer Service on . Posted in Public Companies.
ATLANTA, March 25, 2020 (GLOBE NEWSWIRE) — Williams Industrial Services Group Inc. (OTCQX: WLMS) (“Williams” or the “Company”), a construction and maintenance services company, today reported its financial results for the fiscal fourth quarter and twelve months ended December 31, 2019.Recent HighlightsThe Company posted revenue of $66.8 million for the fourth quarter of 2019, up 50.6% over the prior-year periodWilliams reported net income of $0.2 million, or $0.01 per diluted share, for the fourth quarter versus a loss of $0.5 million, or $(0.03) per diluted share, for the fourth quarter of 2018Adjusted EBITDA1 was $4.2 million and $12.6 million for the fourth quarter and full year 2019, respectively, and the Company expects to achieve $13 million to $15 million in Adjusted EBITDA for the full year 2020The year-end backlog was $494.9...
ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome
Written by Customer Service on . Posted in Public Companies.
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced that Company management will present and discuss findings from a planned three-month interim analysis of its Phase 1/2 Stellar trial of QR-421a in adults with Usher syndrome and non-syndromic retinitis pigmentosa on March 31, 2020. The findings will be announced in a press release and management will host an investor conference call at 8:15 a.m. ET the same day to discuss the results in detail.The live and archived webcast of this presentation can be accessed through the Events and Presentations page on the Investors section of the Company’s website, www.ProQR.com. The dial-in...
Celsion Corporation Reports 2019 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Public Companies.
Enters 2020 with a Strong Balance Sheet and an Advancing Clinical PipelineConference Call Begins at 11:00 a.m. Eastern Time on Thursday March 26, 2020LAWRENCEVILLE, N.J., March 25, 2020 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the year ended December 31, 2019 and provided an update on clinical development programs with ThermoDox®, its proprietary heat-activated liposomal encapsulation of doxorubicin, and GEN-1, an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell transfection followed by persistent, local secretion of the IL-12 protein. The Company’s lead program is ThermoDox®, which is currently in Phase III development for the treatment of hepatocellular carcinoma (HCC), or primary liver cancer. The...
MEGA URANIUM ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING
Written by Customer Service on . Posted in Public Companies.
TORONTO, March 25, 2020 (GLOBE NEWSWIRE) — Mega Uranium Ltd. (TSX: MGA) announces the results of its annual shareholder meeting held earlier today. Each of the nominees listed below was elected as a director by a show of hands of the majority of shareholders. The results of the shares voted in person or by proxy in respect of the election of each director are:At the meeting, shareholders also appointed Ernst & Young LLP as the company’s auditors, to hold office until the next annual meeting.Complete voting results of the meeting are available under the company’s profile on sedar.com.ABOUT MEGA URANIUM LTD.Mega Uranium Ltd. is a Toronto-based mineral resources company with a focus on uranium properties in Australia and Canada and a portfolio of equity investments in uranium-focused public and private companies. Further information...
Inuvo Announces Unaudited Financial Results for the Fourth Quarter and Full Year Ending December 31, 2019
Written by Customer Service on . Posted in Public Companies.
IntentKey generated approximately $8.5 million in revenue for the full year 2019IntentKey revenue is expected to increase 48% in the first quarter of 2020 compared to the prior year periodLITTLE ROCK, Ark., March 25, 2020 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by IntentKey™ artificial intelligence that serves brands and agencies, today announced its preliminary unaudited financial results for the fourth quarter and full year period ending December 31, 2019. Revenue for the 2019 fourth quarter and full year totaled $18.2 million and $61.5 million, respectively. IntentKey, Inuvo’s proprietary machine learning technology, accounted for approximately 14% of 2019 revenue generating $8.5 million during its first full year of operation.Richard Howe, CEO of Inuvo, commented,...
SP Plus Corporation Enters into Enhanced Premier Group Purchasing Agreement with Acurity
Written by Customer Service on . Posted in Public Companies.
CHICAGO, March 25, 2020 (GLOBE NEWSWIRE) — SP Plus Corporation (SP+), (Nasdaq: SP), a leading provider of technology-driven mobility solutions for aviation, commercial, hospitality and institutional clients throughout North America, today announced the award of an enhanced group purchasing agreement with Acurity, Inc., a New York-based regional group purchasing organization in the healthcare category, which became a wholly-owned subsidiary of Premier, Inc. in February 2020.Effective April 1, 2020, the new agreement designates SP+ as Acurity’s contracted supplier for parking and transportation operations, including parking management, valet, patient transport, shuttle and a variety of other related mobility services.“We’re excited to have an opportunity to work with SP+ and to provide its quality management services to our membership...